David Goldstein

Columbia University, New York, NY 
"David Goldstein"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zoghbi AW, Dhindsa RS, Goldberg TE, et al. (2021) High-impact rare genetic variants in severe schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 118
Nickols NG, Goetz MB, Graber CJ, et al. (2021) Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial. Trials. 22: 431
Amador A, Bostick CD, Olson H, et al. (2020) Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice. Brain : a Journal of Neurology
Desch K, Ozel AB, Halvorsen M, et al. (2020) Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. Blood
Kokkinos J, Ignacio RMC, Sharbeen G, et al. (2020) Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs. Biomaterials. 240: 119742
Wang X, Goldstein DB. (2020) Enhancer Domains Predict Gene Pathogenicity and Inform Gene Discovery in Complex Disease. American Journal of Human Genetics. 106: 215-233
Gelfman S, Dugger SA, Araujo Martins Moreno C, et al. (2019) A new approach for rare variation collapsing on functional protein domains implicates specific genic regions in ALS. Genome Research
Hayes SA, Martin A, Yip S, et al. (2019) Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG) Cancer Research. 79: 4531-4531
Halvorsen M, Samuels J, Wang Y, et al. (2019) Rare And De Novo Variants In Obsessive Compulsive Disorder European Neuropsychopharmacology. 29
Chiorean EG, Von Hoff D, Wan Y, et al. (2018) Performance status dynamics during treatment with -paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer. Cancer Management and Research. 10: 1389-1396
See more...